How to Read a Certificate of Analysis (COA)

What Is a Certificate of Analysis?

A Certificate of Analysis is a quality control document issued by a laboratory that tests a product against a set of specifications and reports whether it meets those standards. For peptides, a COA verifies the identity (is it actually the peptide claimed), purity (how much of the product is the target peptide versus impurities), and safety (endotoxin levels, sterility, residual solvents) of each batch produced.

In the pharmaceutical world, COAs are mandatory documentation required by regulatory agencies. In the research peptide market, they are the primary (and sometimes only) quality assurance mechanism available to consumers. Because research peptides are not subject to FDA oversight for quality, the COA becomes your first and best line of defense against contaminated, underdosed, or misidentified products.

A proper COA should be batch-specific, meaning it corresponds to the exact production run from which your product was drawn. It should include the compound name, batch or lot number, date of analysis, testing laboratory name, and results for each test performed. Generic COAs without batch numbers, undated COAs, or COAs that look identical across different products are warning signs.

HPLC Purity Analysis

High-Performance Liquid Chromatography (HPLC) is the standard method for determining peptide purity. It works by dissolving the peptide sample in a solvent and passing it through a column packed with material that separates molecules based on their chemical properties. Different peptides and impurities move through the column at different rates, producing distinct peaks on a chromatogram.

The main peak on an HPLC chromatogram represents your target peptide. The area under this peak, expressed as a percentage of total peak area, is the purity. A peptide with 99.2% HPLC purity means that 99.2% of the detected material is the target peptide and 0.8% consists of impurities such as deletion sequences, oxidized forms, or truncated peptides.

For injectable peptides, you should look for a minimum purity of 98%. Pharmaceutical-grade peptides typically exceed 99%. Research-grade peptides commonly range from 95% to 99%. Below 95%, the impurity load becomes concerning, particularly for compounds being injected subcutaneously. For oral peptides like BPC-157 taken in capsule form, slightly lower purity (95%+) is more acceptable because the gastrointestinal tract provides a natural filter.

Reading the Chromatogram

If the COA includes the actual HPLC chromatogram (the graphical output), look for a single dominant peak with minimal smaller peaks. The x-axis represents retention time (minutes) and the y-axis represents signal intensity. A clean chromatogram shows one tall, sharp peak with a flat baseline and no significant secondary peaks. Multiple large peaks or a noisy baseline suggest impurities or degradation.

The retention time of the main peak should be consistent with the known retention time for that specific peptide under the stated chromatographic conditions. While you will not be able to verify this yourself, comparing COAs from different batches of the same peptide from the same supplier should show consistent retention times. Large variations suggest inconsistency in the product or testing.

Mass Spectrometry (MS)

While HPLC tells you how pure the sample is, mass spectrometry tells you what the sample actually is. MS measures the molecular weight of the peptide and compares it to the known theoretical molecular weight. If the measured mass matches the expected mass, identity is confirmed. If it does not match, the product is either mislabeled, degraded, or a completely different compound.

The COA should report the observed molecular weight and the theoretical (expected) molecular weight. These should match within a tolerance of approximately plus or minus 1 Dalton for most peptide mass spectrometry methods. For example, BPC-157 has a theoretical molecular weight of 1419.53 Da. An observed weight of 1419.4 to 1419.6 Da confirms identity. An observed weight of 1350 Da or 1500 Da indicates the wrong peptide.

Some COAs will include the mass spectrum itself, which shows peaks at various mass-to-charge ratios. The dominant peak should correspond to the target peptide. Multiple charge states (e.g., [M+2H]2+, [M+3H]3+) are normal and actually provide additional confirmation of the molecular weight calculation.

Endotoxin Testing (LAL)

Endotoxins are fragments of bacterial cell walls (specifically lipopolysaccharides from gram-negative bacteria) that can cause severe inflammatory reactions, fever, and in extreme cases, septic shock when injected. Even after sterilization kills bacteria, endotoxins can remain in the product because they are heat-stable and chemically resistant.

The Limulus Amebocyte Lysate (LAL) test is the standard method for detecting endotoxins. Results are reported in Endotoxin Units per milligram (EU/mg) or Endotoxin Units per milliliter (EU/mL). The USP limit for injectable products is less than 5 EU per kilogram of body weight per hour. For practical purposes, peptide COAs should show endotoxin levels well below 5 EU/mg, ideally less than 1 EU/mg.

This is arguably the most important safety test on a COA. A peptide can be pure and correctly identified but still dangerous if contaminated with endotoxins. Many lower-quality suppliers skip endotoxin testing because it requires specialized equipment and adds cost. If a COA for an injectable peptide does not include endotoxin results, treat it as incomplete.

Sterility Testing

Sterility testing confirms the absence of viable microorganisms in the product. For lyophilized (freeze-dried) peptides that will be reconstituted before use, sterility testing ensures the powder itself is not contaminated. For pre-reconstituted or ready-to-inject products, sterility testing is even more critical.

Standard sterility testing involves incubating samples of the product in growth media for 14 days under conditions that support bacterial and fungal growth. If no growth is observed, the product passes. Results are typically reported as “Pass” or “No growth observed.”

Not all suppliers perform sterility testing on every batch. When testing is not included on the COA, assume the product has not been tested for sterility. Using proper aseptic technique during reconstitution and bacteriostatic water for reconstitution provides a layer of protection, but it cannot compensate for a contaminated starting product.

Appearance and Solubility

COAs typically include a visual description of the product. Most lyophilized peptides should appear as a white to off-white powder or lyophilized cake. Significant discoloration (yellow, brown, gray) can indicate degradation, contamination, or improper manufacturing. The powder should dissolve readily in the recommended solvent (usually bacteriostatic water or sterile water) to form a clear, colorless to slightly opalescent solution.

When you receive your peptide and reconstitute it, compare what you observe to what the COA describes. If the COA says “white lyophilized powder, clear solution upon reconstitution” but your product is yellowish with particles floating after reconstitution, something is wrong. Do not inject products that do not match the described appearance. Contact the supplier for a replacement or refund.

Amino Acid Analysis

Amino acid analysis breaks down the peptide into its individual amino acid components and measures the ratio of each. Since every peptide has a known amino acid sequence, the measured ratios should match the theoretical ratios. This test provides another layer of identity confirmation beyond mass spectrometry.

This is a less common test on COAs from research peptide suppliers due to its cost and complexity. When present, it is a strong positive indicator of quality assurance. Pharmaceutical-grade COAs almost always include amino acid analysis. Research-grade COAs rarely do. It is not a dealbreaker if absent, provided HPLC and MS data are present and satisfactory.

Red Flags in a COA

• No batch or lot number. Without a batch number, the COA cannot be linked to your specific product. It may be a generic template applied to every shipment.
• No date of analysis. An undated COA could be months or years old. Peptide stability changes over time, and a COA from a year-old batch tells you nothing about the current product.
• No testing laboratory identified. A legitimate COA identifies the laboratory that performed the testing. If no lab is named, the results cannot be verified independently.
• Purity exactly 99.00% on every product. No manufacturing process produces exactly the same purity for every compound in every batch. If a supplier shows 99.00% HPLC purity for BPC-157, TB-500, CJC-1295, and every other peptide they sell, the COAs are likely fabricated.
• No mass spectrometry data. Without MS, identity is unconfirmed. You are taking the supplier's word for what is in the vial.
• No endotoxin testing for injectable products. This is a safety concern. Endotoxin contamination cannot be detected visually or by any user-accessible method.
• COA looks identical across different batch numbers. Compare COAs from different purchases. Legitimate testing produces slightly different numbers each time. Identical results across batches are suspicious.
• Supplier refuses to provide a COA. Any supplier unwilling to share testing documentation is not worth your business, period.

Third-Party Testing

The gold standard for product verification is third-party testing, where an independent laboratory analyzes the product without any relationship to the manufacturer or supplier. Supplier-provided COAs inherently carry a conflict of interest. The supplier benefits from showing favorable results, and there is no external verification that the testing was actually performed on the specific product being sold.

Several online communities and consumer groups have organized third-party testing programs where members pool resources to send products from various suppliers to independent analytical laboratories. The results are published openly, creating accountability and transparency that individual COAs cannot provide. Participating in or reviewing results from these programs is one of the best ways to identify reliable suppliers.

If you want to commission your own third-party testing, analytical laboratories that perform peptide analysis are available, though the cost for a full panel (HPLC, MS, endotoxin) can range from two hundred to five hundred dollars or more per sample. For expensive peptides or long-term use, this investment provides peace of mind that is difficult to obtain any other way.

Compounding pharmacies licensed under 503A or 503B regulations are required to perform quality testing and maintain records. When you obtain peptides through a licensed compounding pharmacy with a valid prescription, the regulatory framework provides a level of quality assurance that the research chemical market does not.

Frequently Asked Questions